|
GPBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.170380E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.595000E-03 |
| Normal-vs-Stage2 |
1.803050E-01 |
| Normal-vs-Stage3 |
5.203800E-01 |
| Normal-vs-Stage4 |
2.249400E-01 |
| Stage1-vs-Stage2 |
7.572200E-01 |
| Stage1-vs-Stage3 |
1.010190E-04 |
| Stage1-vs-Stage4 |
3.9497000000055E-05 |
| Stage2-vs-Stage3 |
8.110000E-02 |
| Stage2-vs-Stage4 |
3.927700E-02 |
| Stage3-vs-Stage4 |
5.321200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.334180E-01 |
| Normal-vs-AfricanAmerican |
4.114000E-01 |
| Normal-vs-Asian |
4.275400E-01 |
| Caucasian-vs-AfricanAmerican |
9.177600E-01 |
| Caucasian-vs-Asian |
5.337800E-01 |
| AfricanAmerican-vs-Asian |
5.276600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.260600E-01 |
| Normal-vs-Female |
7.699600E-02 |
| Male-vs-Female |
4.140000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.304600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.253020E-01 |
| Normal-vs-Age(61-80Yrs) |
1.043820E-01 |
| Normal-vs-Age(81-100Yrs) |
9.556000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.020400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.839850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.810200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.326200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.172000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.900000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.867700E-02 |
| Normal-vs-Grade 2 |
1.761750E-04 |
| Normal-vs-Grade 3 |
7.759400E-01 |
| Normal-vs-Grade 4 |
8.759200E-03 |
| Grade 1-vs-Grade 2 |
9.039400E-01 |
| Grade 1-vs-Grade 3 |
1.750790E-01 |
| Grade 1-vs-Grade 4 |
3.882200E-03 |
| Grade 2-vs-Grade 3 |
8.27190000000089E-05 |
| Grade 2-vs-Grade 4 |
1.407099992079E-09 |
| Grade 3-vs-Grade 4 |
2.924300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.99839999995388E-06 |
| Normal-vs-ccB subtype |
3.514400E-01 |
| ccA subtype-vs-ccB subtype |
4.45269998650133E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.564190E-01 |
| Normal-vs-N1 |
1.638790E-01 |
| N0-vs-N1 |
1.180210E-01 |
|
|
